search
Back to results

Relationship Between Nitric Oxide (NO) in Follicular Fluid and Sperm Fertilization Ability

Primary Purpose

Male Infertility

Status
Unknown status
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Control (fertile semen donors)
Patients (subfertile men)
Sponsored by
IVI Murcia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Male Infertility focused on measuring nitric oxide, follicular fluid, sperm, capacitation, fertilization, phosphorylation, nitrosylation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • This study will include fertile males such as the semen donors attending the clinic IVI Murcia and a group of subfertile males composed of patients, who attend the clinic to undergo an in vitro fertilization treatment and who possess one altered spermiogram parameter (according to the WHO 2010 guidelines). These participants will be recruited to examine the modifications in the NOS expression as well as the protein nitrosylation in fertile and subfertile men.
  • This study will also include couples who undergo an IVF or ICSI treatment, in order to investigate if the effects of human follicular fluid on sperm capacitation are associated to NO levels in the fluid and to identify the correlation between NO levels in the follicular fluid and the clinical outcomes from ARTs.

Exclusion Criteria:

  • From this study will be excluded couples who undergo preimplantation genetic diagnosis, were diagnosed with repetitive abortion (three or more consecutive abortions before week 20) or implantation failure (lack of pregnancy after three embryo transfers with good quality embryos in women under 36 years of age or after two embryo transfers in women over 36 years of age), as well as women over 40 years of age.

Sites / Locations

  • IVI MurciaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Control (fertile semen donors)

Patients (subfertile men)

Arm Description

Sperm from fertile men (donors who attend the IVI Murcia clinic) will be included in this arm.

Sperm from patients (subfertile men, i.e. men who possess one altered spermiogram parameter, according to the WHO 2010 guidelines) will be included in this arm.

Outcomes

Primary Outcome Measures

Nitric Oxide levels in follicular fluid
Upon collection and after oocyte removal, the follicular fluid samples will be centrifuged to remove cellular debris. An aliquot will be further centrifuged in tubes with 10 kDa filters to remove proteins. This alliquot will then be used to determine NO concentration with the help of a commercially available measurement system. NO is rapidly oxidized into two stable ions, namely nitrite and nitrate, which can be assayed by using ions selective electrodes. A software will then be used to calculate the initial concentration of Nitric Oxide (micromolar).

Secondary Outcome Measures

Full Information

First Posted
October 6, 2017
Last Updated
October 18, 2017
Sponsor
IVI Murcia
Collaborators
Universidad de Murcia, Harvard School of Public Health (HSPH), European Commission
search

1. Study Identification

Unique Protocol Identification Number
NCT03307655
Brief Title
Relationship Between Nitric Oxide (NO) in Follicular Fluid and Sperm Fertilization Ability
Official Title
Relationship Between Nitric Oxide (NO) in Follicular Fluid and Sperm Fertilization Ability
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Unknown status
Study Start Date
September 21, 2017 (Actual)
Primary Completion Date
December 2018 (Anticipated)
Study Completion Date
October 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
IVI Murcia
Collaborators
Universidad de Murcia, Harvard School of Public Health (HSPH), European Commission

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Several studies indicate that Nitric Oxide (NO) plays an important role in the physiology of the reproductive system in mammals. It has been shown that NO affects sperm motility, it regulates the tyrosine phosphorylation of different sperm proteins, it enhances the sperm binding ability to the zona pellucida and it modulates the acrosome reaction. The enzyme responsible for NO synthesis, the Nitric Oxide Synthase (NOS), has also been identified in the oocytes, cumulus and corona cells, as well as in the oviduct. For these reasons, the NOS presence at the fertilization site could be a key element to determine the success of this process. Therefore, carrying out in vitro studies to better understand NO's role in the fertilization process, especially in human sperm capacitation, could improve the outcome of the Assisted Reproductive Techniques (ARTs) due to an improvement both in the diagnosis of infertility and in the prognosis of treatment success. This study is carried out in collaboration with the Animal Physiology Department from the Veterinary Faculty (University of Murcia, Spain) and it is funded by the European Commission under the Horizon 2020 Programme.
Detailed Description
Main Objective: Determine changes in the NOS expression and protein nitrosylation in fertile and infertile patients, when adding L-Arginine, the substrate for NO synthesis, to the sperm capacitation medium in the presence/absence of human follicular fluid (hFF). Secondary Objectives: Investigate if the effects of hFF on sperm capacitation are associated to NO levels in the fluid. Identify the correlation between NO levels in hFF and the clinical outcomes from ARTs. METHODOLOGY A. Population The population included in the study will comprise both semen donors and couples attending the clinic IVI Murcia for a treatment of assisted reproduction via techniques of in vitro fertilization. B. Inclusion / exclusion criteria Depending on the objectives, both the population and inclusion and exclusion criteria may vary. Inclusion criteria Main Objective To examine the modifications in the NOS expression as well as the protein nitrosylation in fertile and subfertile patients. For this purpose, the following groups will be recruited: a group of fertile males, such as the semen donors attending the clinic IVI Murcia; a group of subfertile males composed of patients, who attend the clinic IVI Murcia to undergo an in vitro fertilization treatment and who possess one altered spermiogram parameter, according to the WHO (2010) guidelines. In order to reach the Secondary Objectives, couples who undergo an IVF or ICSI treatment will be included. Exclusion criteria Will be excluded couples who undergo preimplantation genetic diagnosis, were diagnosed with repetitive abortion (three or more consecutive abortions before week 20) or implantation failure (lack of pregnancy after three embryo transfers with good quality embryos in women under 36 years of age or after two embryo transfers in women over 36 years of age), as well as women over 40 years of age. C. Sample size: Since reference values for NOS expression are not available and since the variability of the distribution of progressive spermatozoa is high, it has been determined that to detect a difference of 20% with respect to the mean in a bilateral test, with a level of significance of 5% and 80% of statistical power, 41 semen samples per group will be necessary. A period of 24 months is estimated to reach the number of seminal samples. D. Experimental design and interventions Biomedical research study with control group (fertile semen donors) and experimental group (subfertile males) Interventions: Semen samples: will be obtained by masturbation after 2-7 days of sexual abstinence. All samples will be analyzed according to WHO guidelines (2010). To avoid unnecessary visits for the men included in the study, the semen sample will be requested during one of their visits to the clinic. Spermatozoa will be capacitated in the presence and absence of hFF. In a first set of experiments, the hFF will be supplemented with L-Arginine and the NOS inhibitor L-NAME. In another set of experiments the same supplementations to the capacitation medium will be examined, but without using hFF. A series of techniques such as Western blot, in situ nitrosylation and Biotin Switch Assay will be used to determine any changes in the NOS expression and protein nitrosylation in spermatozoa. The Western blot technique will also be applied to evaluate other capacitation markers such as the Protein Kinase A (PKA) activity, tyrosine phosphorylation and tyrosine nitration. The same treatment will be performed on all semen samples regardless of whether they come from patients or from semen donors. IN NO CASE WILL THESE SEMEN SAMPLES BE USED TO PERFORM AN ASSISTED REPRODUCTION TREATMENT. Human follicular fluid samples: To study the correlation between the NO concentration in follicular fluid and the success of the assisted reproduction treatment, the follicular fluid samples will be obtained during the oocyte pick up procedure. After oocyte removal, these fluids are normally eliminated, but in this case the fluids will be centrifuged for 10 minutes at 2000g and stored at -20°C until evaluation. The NO concentration will be determined with the help of a commercially available measurement system. NO is rapidly oxidized into two stable ions, namely nitrite and nitrate, which can be assayed by using ions selective electrodes. These electrodes have been miniaturized to be able to measure samples down to 30-40 µl with detection limits down to the low µM range for both species. The Western blot and protein nitrosylation assays will be performed inside the Animal Physiology laboratory, at the University of Murcia (Faculty of Veterinary Medicine). It should be noted that the only objective of analyzing the follicular fluid is to investigate after the assisted reproduction treatment if there is any correlation between the result of the treatment and the NO levels. Under no circumstances will embryo transfer decisions be made based on the NO levels in the follicular fluid. E. Collection of biological samples Sperm and follicular fluid samples will be evaluated in the present study. Purpose of sample collection The samples collected in the present study will only be used for the completion of the research project. To each biological sample a code will be assigned, which will be independent from the NHC code (number of clinical history) of the patients and will only be known by the research team. Dr. Juan Carlos Martínez Soto will be responsible for the storage and safekeeping of the biological samples. Method for sample collection The biological samples will only be obtained once the patient has signed the corresponding informed consent. The seminal samples will be obtained by masturbation after 2-7 days of sexual abstinence. To avoid unnecessary displacements, the sample collection will take place during the visit of the patient to the clinic. The follicular fluid samples will be obtained on the day of the oocyte pick up procedure performed for the in vitro fertilization treatment that the patients will follow. This fluid, which is normally discarded, will be used only to determine NO values. Obtaining this follicular fluid does not pose any additional risk or discomfort to those caused by the reproduction treatment, since the surgical procedure of oocyte pick up is used to obtain the follicular fluid. Method for sample identification The semen and follicular fluid samples will be identified in a way which will allow to safeguard the identity of the participants. Sample conservation Both seminal and follicular fluid samples will be stored in freezers in the laboratory of Andrology (IVI Murcia) at -80°C until further processing, under the supervision of Dr Juan Carlos Martínez Soto. The samples sent to the University of Murcia will be stored by Dr. Carmen Matás Parra. Both the facilities of the University of Murcia and those of the IVI clinic have a restricted access, therefore the samples will be always guarded. Upon completion of the study (January 2019), the surplus samples will be destroyed following the usual protocols of the clinic. F. Database The data regarding sample analysis (follicular fluid and semen samples), will be stored in Excel tables in the facilities of IVI Murcia. The data regarding the results of the assisted reproduction treatments that have been followed by the patients included in the study will be obtained from the IVI management system (SIVIS). G. Study variables Four classes of variables will be distinguished according to their relevance within the study: Primary Variable: NO levels. Secondary Variables: NOS expression, rate of progressive sperm, pregnancy rate, biochemical pregnancy, pregnancy evolution, implantation rate, ectopic pregnancy rate. Control Variables: Tyrosine phosphorylation (optical density units), PKA (optical density units), protein nitrosylation (optical density units), nitrates and nitrites (micromolar units). Descriptive variables: maternal age, paternal age, male etiology, female etiology, BMI, smoking habit. H. Data analysis Descriptive analysis: Statistical summary of the data collected in the study. Categorical data will be presented in frequency tables and histograms. The continuous values will be summarized with the mean, standard deviation and confidence interval, they will be represented by graphs of quartiles or densities. The exploratory analysis of the data will allow to assess the quality of the data and the detection of anomalies. Analysis of homogeneity: The means and proportions of the descriptive variables (baseline and demographic) will be compared to validate the degree of comparability of the study groups. S chi-square test will be applied in the categorical variables and, assuming the data follow a normal distribution, a T-test in the continuous variables. If the data does not follow a normal distribution, a Mann-Whitney test would be applied. In the case of finding descriptive variables distributed in a way that there are statistical differences between the groups, they will be included in a regression model, to control their interference in the main relation to be studied. Comparison of NO expression: To validate a hypothesis of correlation of proportions in the NO expression, a Fisher test will be applied. To evaluate the effect of other covariables that can modify the behavior of NO expression, a logistic regression model will be defined. As for the comparison of protein nitrosylation, a Student's t-test will be applied assuming that the data follow a normal distribution. If the normality assumption will not be met, verified by a Kolmogorov-Smirnof test, a non-parametric U-MannWhitney test would be applied. In the same way, a linear regression model will be defined that allows the evaluation of the effect of other correlated variables. Evaluation of seminal quality: For the set of variables that make up the seminal quality, a t-Student test will be applied assuming that the data follow a normal distribution. If the normality assumption will not be met, verified by a Kolmogorov-Smirnof test, a non-parametric U-MannWhitney test would be applied. Evaluation of gestational outcomes: For the set of variables that define the gestation results, a Fisher test will be applied. Workplan: Development stages and distribution of the tasks of the entire research team, and the assignments planned for the technical staff. Indicate in addition place / center of realization of the project. The design of the study, as well as the drafting of the project have been carried out by Doctors Carmen Matás Parra and Juan Carlos Martínez Soto. The team of gynecologists who make up the Unit of Reproductive Medicine at the IVI Murcia clinic, Dr. Jose Landeras, María Nicolás, Laura Fernández and Martina Trabalón, will be responsible for the inclusion of patients and semen donors in the study, as well as the direct responsible for the assisted reproduction treatment performed on patients. Such treatment includes: the choice of treatment to be performed, ovarian stimulation, oocyte pick up procedure to collect oocytes and follicular fluid, as well as embryo transfer. The embryologists Marta Molla, David Gumbao, Julián Marcos, Beatriz Amorocho and Ana Isabel Sanchez will be responsible for the process of oocyte fertilization in the fertilization laboratory, as well as the selection of embryos to be transferred. Florentin-Daniel Staicu, Carmen Matás Parra and Juan Carlos Martínez Soto will carry out the analysis of both seminal and follicular fluid samples. These analyses will be carried out both in the facilities of the IVI Murcia clinic and in the laboratories of the University of Murcia. Dr. Jorge Chavarro will conduct the epidemiological and biostatistical studies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Male Infertility
Keywords
nitric oxide, follicular fluid, sperm, capacitation, fertilization, phosphorylation, nitrosylation

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Semen and FF samples will be obtained from donors and patients by masturbation after 2-7 days of sexual abstinence and they will be analyzed according to WHO guidelines (2010). FF samples will be obtained during the oocyte pick up procedure. After oocyte removal, the FF will be centrifuged for 10 min at 2000g and stored at -20°C until evaluation. NO concentration will be determined in the FF samples with the help of ion selective electrodes. Sperm will be capacitated in the presence and absence of FF. In a first set of experiments, the FF will be supplemented with L-Arginine and the NOS inhibitor L-NAME. In another set of experiments the same supplementations to the capacitation medium will be examined, but without using FF. Changes in NOS expression, protein nitrosylation, PKA activity, tyrosine phosphorylation and tyrosine nitration in sperm will be determined. The same treatment will be performed on all semen samples regardless of whether they come from patients or donors.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
82 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control (fertile semen donors)
Arm Type
Experimental
Arm Description
Sperm from fertile men (donors who attend the IVI Murcia clinic) will be included in this arm.
Arm Title
Patients (subfertile men)
Arm Type
Experimental
Arm Description
Sperm from patients (subfertile men, i.e. men who possess one altered spermiogram parameter, according to the WHO 2010 guidelines) will be included in this arm.
Intervention Type
Other
Intervention Name(s)
Control (fertile semen donors)
Intervention Description
The sperm will be capacitated in the presence and absence of follicular fluid (FF). In a first set of experiments, the FF will be supplemented with L-Arginine and the NOS inhibitor L-NAME. In another set of experiments the same supplementations to the capacitation medium will be examined, but without using FF. Changes in NOS expression, protein nitrosylation, PKA activity, tyrosine phosphorylation and tyrosine nitration in sperm will be determined.
Intervention Type
Other
Intervention Name(s)
Patients (subfertile men)
Intervention Description
The sperm will be capacitated in the presence and absence of follicular fluid (FF). In a first set of experiments, the FF will be supplemented with L-Arginine and the NOS inhibitor L-NAME. In another set of experiments the same supplementations to the capacitation medium will be examined, but without using FF. Changes in NOS expression, protein nitrosylation, PKA activity, tyrosine phosphorylation and tyrosine nitration in sperm will be determined.
Primary Outcome Measure Information:
Title
Nitric Oxide levels in follicular fluid
Description
Upon collection and after oocyte removal, the follicular fluid samples will be centrifuged to remove cellular debris. An aliquot will be further centrifuged in tubes with 10 kDa filters to remove proteins. This alliquot will then be used to determine NO concentration with the help of a commercially available measurement system. NO is rapidly oxidized into two stable ions, namely nitrite and nitrate, which can be assayed by using ions selective electrodes. A software will then be used to calculate the initial concentration of Nitric Oxide (micromolar).
Time Frame
Nitrit Oxide levels will be measured within 30 min after the follicular fluid sample is available.

10. Eligibility

Sex
All
Gender Based
Yes
Gender Eligibility Description
This study will include: fertile and subfertile men (who will provide the semen samples) and women donors (who will provide the follicular fluid samples).
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: This study will include fertile males such as the semen donors attending the clinic IVI Murcia and a group of subfertile males composed of patients, who attend the clinic to undergo an in vitro fertilization treatment and who possess one altered spermiogram parameter (according to the WHO 2010 guidelines). These participants will be recruited to examine the modifications in the NOS expression as well as the protein nitrosylation in fertile and subfertile men. This study will also include couples who undergo an IVF or ICSI treatment, in order to investigate if the effects of human follicular fluid on sperm capacitation are associated to NO levels in the fluid and to identify the correlation between NO levels in the follicular fluid and the clinical outcomes from ARTs. Exclusion Criteria: From this study will be excluded couples who undergo preimplantation genetic diagnosis, were diagnosed with repetitive abortion (three or more consecutive abortions before week 20) or implantation failure (lack of pregnancy after three embryo transfers with good quality embryos in women under 36 years of age or after two embryo transfers in women over 36 years of age), as well as women over 40 years of age.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Juan Carlos Martinez Soto, MD, PhD
Phone
+34666676183
Email
JuanCarlos.Martinez@ivi.es
First Name & Middle Initial & Last Name or Official Title & Degree
Carmen Matas Parra, Professor
Phone
+34669031210
Email
cmatas@um.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carmen Matas Parra, Professor
Organizational Affiliation
University of Murcia (Spain)
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Juan Carlos Martinez Soto, MD, PhD
Organizational Affiliation
IVI Murcia (Spain)
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Jorge Chavarro, MD, PhD
Organizational Affiliation
Harvard University
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Florentin-Daniel Staicu, MSc
Organizational Affiliation
University of Murcia (Spain)
Official's Role
Principal Investigator
Facility Information:
Facility Name
IVI Murcia
City
Murcia
ZIP/Postal Code
30007
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Juan Carlos Martinez Soto, MD, PhD
Phone
+34666676183
Email
JuanCarlos.Martinez@ivi.es

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The IPD will not be shared at any point during this study. To preserve participant's anonymity, the biological samples (semen and follicular fluid) that will be collected will be identified with a code which will be different from the Number of Clinical History of the donors/patients.
Citations:
PubMed Identifier
24194470
Citation
Okabe M. The cell biology of mammalian fertilization. Development. 2013 Nov;140(22):4471-9. doi: 10.1242/dev.090613.
Results Reference
background
PubMed Identifier
25542028
Citation
Romero-Aguirregomezcorta J, Santa AP, Garcia-Vazquez FA, Coy P, Matas C. Nitric oxide synthase (NOS) inhibition during porcine in vitro maturation modifies oocyte protein S-nitrosylation and in vitro fertilization. PLoS One. 2014 Dec 26;9(12):e115044. doi: 10.1371/journal.pone.0115044. eCollection 2014.
Results Reference
background
PubMed Identifier
1537574
Citation
Gutteridge JM, Halliwell B. Comments on review of Free Radicals in Biology and Medicine, second edition, by Barry Halliwell and John M. C. Gutteridge. Free Radic Biol Med. 1992;12(1):93-5. doi: 10.1016/0891-5849(92)90062-l. No abstract available.
Results Reference
background
PubMed Identifier
7539994
Citation
Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol. 1995;57:707-36. doi: 10.1146/annurev.ph.57.030195.003423. No abstract available.
Results Reference
background
PubMed Identifier
7545786
Citation
Snyder SH. Nitric oxide. No endothelial NO. Nature. 1995 Sep 21;377(6546):196-7. doi: 10.1038/377196a0. No abstract available.
Results Reference
background
PubMed Identifier
9239673
Citation
Rosselli M, Dubey RK, Rosselli MA, Macas E, Fink D, Lauper U, Keller PJ, Imthurn B. Identification of nitric oxide synthase in human and bovine oviduct. Mol Hum Reprod. 1996 Aug;2(8):607-12. doi: 10.1093/molehr/2.8.607.
Results Reference
background
PubMed Identifier
16935840
Citation
Lapointe J, Roy M, St-Pierre I, Kimmins S, Gauvreau D, MacLaren LA, Bilodeau JF. Hormonal and spatial regulation of nitric oxide synthases (NOS) (neuronal NOS, inducible NOS, and endothelial NOS) in the oviducts. Endocrinology. 2006 Dec;147(12):5600-10. doi: 10.1210/en.2005-1548. Epub 2006 Aug 24.
Results Reference
background
PubMed Identifier
15277009
Citation
Reyes R, Vazquez ML, Delgado NM. Detection and bioimaging of nitric oxide in bovine oocytes and sperm cells. Arch Androl. 2004 Jul-Aug;50(4):303-9. doi: 10.1080/01485010490448471.
Results Reference
background
PubMed Identifier
15249129
Citation
Tao Y, Fu Z, Zhang M, Xia G, Yang J, Xie H. Immunohistochemical localization of inducible and endothelial nitric oxide synthase in porcine ovaries and effects of NO on antrum formation and oocyte meiotic maturation. Mol Cell Endocrinol. 2004 Jul 30;222(1-2):93-103. doi: 10.1016/j.mce.2004.04.014.
Results Reference
background
PubMed Identifier
9070716
Citation
Ekerhovd E, Brannstrom M, Alexandersson M, Norstrom A. Evidence for nitric oxide mediation of contractile activity in isolated strips of the human Fallopian tube. Hum Reprod. 1997 Feb;12(2):301-5. doi: 10.1093/humrep/12.2.301.
Results Reference
background
PubMed Identifier
7561611
Citation
Bryant CE, Tomlinson A, Mitchell JA, Thiemermann C, Willoughby DA. Nitric oxide synthase in the rat fallopian tube is regulated during the oestrous cycle. J Endocrinol. 1995 Jul;146(1):149-57. doi: 10.1677/joe.0.1460149.
Results Reference
background
PubMed Identifier
9247138
Citation
Herrero MB, Goin JC, Boquet M, Canteros MG, Franchi AM, Perez Martinez S, Polak JM, Viggiano JM, Gimeno MA. The nitric oxide synthase of mouse spermatozoa. FEBS Lett. 1997 Jul 7;411(1):39-42. doi: 10.1016/s0014-5793(97)00570-x.
Results Reference
background
PubMed Identifier
14651478
Citation
Meiser H, Schulz R. Detection and localization of two constitutive NOS isoforms in bull spermatozoa. Anat Histol Embryol. 2003 Dec;32(6):321-5. doi: 10.1111/j.1439-0264.2003.00459.x.
Results Reference
background
PubMed Identifier
8876053
Citation
Herrero MB, Perez Martinez S, Viggiano JM, Polak JM, de Gimeno MF. Localization by indirect immunofluorescence of nitric oxide synthase in mouse and human spermatozoa. Reprod Fertil Dev. 1996;8(5):931-4. doi: 10.1071/rd9960931.
Results Reference
background
PubMed Identifier
9848308
Citation
O'Bryan MK, Zini A, Cheng CY, Schlegel PN. Human sperm endothelial nitric oxide synthase expression: correlation with sperm motility. Fertil Steril. 1998 Dec;70(6):1143-7. doi: 10.1016/s0015-0282(98)00382-3.
Results Reference
background
PubMed Identifier
17280805
Citation
Hou ML, Huang SY, Lai YK, Lee WC. Geldanamycin augments nitric oxide production and promotes capacitation in boar spermatozoa. Anim Reprod Sci. 2008 Feb 1;104(1):56-68. doi: 10.1016/j.anireprosci.2007.01.006. Epub 2007 Jan 10.
Results Reference
background
PubMed Identifier
7515230
Citation
Rosselli M, Imthurn B, Macas E, Keller PJ, Dubey RK. Endogenous nitric oxide modulates endothelin-1 induced contraction of bovine oviduct. Biochem Biophys Res Commun. 1994 May 30;201(1):143-8. doi: 10.1006/bbrc.1994.1680.
Results Reference
background
PubMed Identifier
17280661
Citation
Miraglia E, Rullo ML, Bosia A, Massobrio M, Revelli A, Ghigo D. Stimulation of the nitric oxide/cyclic guanosine monophosphate signaling pathway elicits human sperm chemotaxis in vitro. Fertil Steril. 2007 May;87(5):1059-63. doi: 10.1016/j.fertnstert.2006.07.1540. Epub 2007 Feb 5.
Results Reference
background
PubMed Identifier
9607805
Citation
Jablonka-Shariff A, Olson LM. The role of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology. 1998 Jun;139(6):2944-54. doi: 10.1210/endo.139.6.6054.
Results Reference
background
PubMed Identifier
16114873
Citation
Goud AP, Goud PT, Diamond MP, Abu-Soud HM. Nitric oxide delays oocyte aging. Biochemistry. 2005 Aug 30;44(34):11361-8. doi: 10.1021/bi050711f.
Results Reference
background
PubMed Identifier
1382087
Citation
Schmidt HH, Gagne GD, Nakane M, Pollock JS, Miller MF, Murad F. Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem. 1992 Oct;40(10):1439-56. doi: 10.1177/40.10.1382087.
Results Reference
background
PubMed Identifier
10027610
Citation
Cameron IT, Campbell S. Nitric oxide in the endometrium. Hum Reprod Update. 1998 Sep-Oct;4(5):565-9. doi: 10.1093/humupd/4.5.565.
Results Reference
background
PubMed Identifier
9358000
Citation
Donnelly ET, Lewis SE, Thompson W, Chakravarthy U. Sperm nitric oxide and motility: the effects of nitric oxide synthase stimulation and inhibition. Mol Hum Reprod. 1997 Sep;3(9):755-62. doi: 10.1093/molehr/3.9.755.
Results Reference
background
PubMed Identifier
9886494
Citation
Revelli A, Soldati G, Costamagna C, Pellerey O, Aldieri E, Massobrio M, Bosia A, Ghigo D. Follicular fluid proteins stimulate nitric oxide (NO) synthesis in human sperm: a possible role for NO in acrosomal reaction. J Cell Physiol. 1999 Jan;178(1):85-92. doi: 10.1002/(SICI)1097-4652(199901)178:13.0.CO;2-Y.
Results Reference
background
PubMed Identifier
11369599
Citation
Revelli A, Costamagna C, Moffa F, Aldieri E, Ochetti S, Bosia A, Massobrio M, Lindblom B, Ghigo D. Signaling pathway of nitric oxide-induced acrosome reaction in human spermatozoa. Biol Reprod. 2001 Jun;64(6):1708-12. doi: 10.1095/biolreprod64.6.1708.
Results Reference
background
PubMed Identifier
10456831
Citation
Herrero MB, de Lamirande E, Gagnon C. Nitric oxide regulates human sperm capacitation and protein-tyrosine phosphorylation in vitro. Biol Reprod. 1999 Sep;61(3):575-81. doi: 10.1095/biolreprod61.3.575.
Results Reference
background
PubMed Identifier
12606410
Citation
Thundathil J, de Lamirande E, Gagnon C. Nitric oxide regulates the phosphorylation of the threonine-glutamine-tyrosine motif in proteins of human spermatozoa during capacitation. Biol Reprod. 2003 Apr;68(4):1291-8. doi: 10.1095/biolreprod.102.008276. Epub 2002 Oct 30.
Results Reference
background
PubMed Identifier
9531890
Citation
Sengoku K, Tamate K, Yoshida T, Takaoka Y, Miyamoto T, Ishikawa M. Effects of low concentrations of nitric oxide on the zona pellucida binding ability of human spermatozoa. Fertil Steril. 1998 Mar;69(3):522-7. doi: 10.1016/s0015-0282(97)00537-2.
Results Reference
background
PubMed Identifier
7511827
Citation
Murad F. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Recent Prog Horm Res. 1994;49:239-48. doi: 10.1016/b978-0-12-571149-4.50016-7.
Results Reference
background
PubMed Identifier
9679145
Citation
Wiesner B, Weiner J, Middendorff R, Hagen V, Kaupp UB, Weyand I. Cyclic nucleotide-gated channels on the flagellum control Ca2+ entry into sperm. J Cell Biol. 1998 Jul 27;142(2):473-84. doi: 10.1083/jcb.142.2.473.
Results Reference
background
PubMed Identifier
9270304
Citation
Lohmann SM, Vaandrager AB, Smolenski A, Walter U, De Jonge HR. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci. 1997 Aug;22(8):307-12. doi: 10.1016/s0968-0004(97)01086-4.
Results Reference
background
PubMed Identifier
9932482
Citation
Pfeifer A, Ruth P, Dostmann W, Sausbier M, Klatt P, Hofmann F. Structure and function of cGMP-dependent protein kinases. Rev Physiol Biochem Pharmacol. 1999;135:105-49. doi: 10.1007/BFb0033671. No abstract available.
Results Reference
background
PubMed Identifier
24877140
Citation
Rahman MS, Kwon WS, Pang MG. Calcium influx and male fertility in the context of the sperm proteome: an update. Biomed Res Int. 2014;2014:841615. doi: 10.1155/2014/841615. Epub 2014 Apr 27.
Results Reference
background
PubMed Identifier
20965947
Citation
Miraglia E, De Angelis F, Gazzano E, Hassanpour H, Bertagna A, Aldieri E, Revelli A, Ghigo D. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway. Reproduction. 2011 Jan;141(1):47-54. doi: 10.1530/REP-10-0151. Epub 2010 Oct 21.
Results Reference
background
PubMed Identifier
9539809
Citation
Kurtz A, Gotz KH, Hamann M, Wagner C. Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4743-7. doi: 10.1073/pnas.95.8.4743.
Results Reference
background
PubMed Identifier
7480160
Citation
Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev. 1995 Oct;75(4):725-48. doi: 10.1152/physrev.1995.75.4.725.
Results Reference
background
PubMed Identifier
11025196
Citation
Belen Herrero M, Chatterjee S, Lefievre L, de Lamirande E, Gagnon C. Nitric oxide interacts with the cAMP pathway to modulate capacitation of human spermatozoa. Free Radic Biol Med. 2000 Sep 15;29(6):522-36. doi: 10.1016/s0891-5849(00)00339-7.
Results Reference
background
PubMed Identifier
10383385
Citation
McVey M, Hill J, Howlett A, Klein C. Adenylyl cyclase, a coincidence detector for nitric oxide. J Biol Chem. 1999 Jul 2;274(27):18887-92. doi: 10.1074/jbc.274.27.18887.
Results Reference
background
PubMed Identifier
11818515
Citation
de Lamirande E, Gagnon C. The extracellular signal-regulated kinase (ERK) pathway is involved in human sperm function and modulated by the superoxide anion. Mol Hum Reprod. 2002 Feb;8(2):124-35. doi: 10.1093/molehr/8.2.124.
Results Reference
background
PubMed Identifier
17683036
Citation
Lefievre L, Chen Y, Conner SJ, Scott JL, Publicover SJ, Ford WC, Barratt CL. Human spermatozoa contain multiple targets for protein S-nitrosylation: an alternative mechanism of the modulation of sperm function by nitric oxide? Proteomics. 2007 Sep;7(17):3066-84. doi: 10.1002/pmic.200700254.
Results Reference
background
PubMed Identifier
18842814
Citation
Machado-Oliveira G, Lefievre L, Ford C, Herrero MB, Barratt C, Connolly TJ, Nash K, Morales-Garcia A, Kirkman-Brown J, Publicover S. Mobilisation of Ca2+ stores and flagellar regulation in human sperm by S-nitrosylation: a role for NO synthesised in the female reproductive tract. Development. 2008 Nov;135(22):3677-86. doi: 10.1242/dev.024521. Epub 2008 Oct 8.
Results Reference
background
PubMed Identifier
18649275
Citation
Bedu-Addo K, Costello S, Harper C, Machado-Oliveira G, Lefievre L, Ford C, Barratt C, Publicover S. Mobilisation of stored calcium in the neck region of human sperm--a mechanism for regulation of flagellar activity. Int J Dev Biol. 2008;52(5-6):615-26. doi: 10.1387/ijdb.072535kb.
Results Reference
background
PubMed Identifier
23247505
Citation
Kakizawa S, Yamazawa T, Iino M. Nitric oxide-induced calcium release: activation of type 1 ryanodine receptor by endogenous nitric oxide. Channels (Austin). 2013 Jan 1;7(1):1-5. doi: 10.4161/chan.22555. Epub 2012 Dec 17.
Results Reference
background
PubMed Identifier
2725677
Citation
Takeshima H, Nishimura S, Matsumoto T, Ishida H, Kangawa K, Minamino N, Matsuo H, Ueda M, Hanaoka M, Hirose T, et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature. 1989 Jun 8;339(6224):439-45. doi: 10.1038/339439a0.
Results Reference
background
PubMed Identifier
2380170
Citation
Otsu K, Willard HF, Khanna VK, Zorzato F, Green NM, MacLennan DH. Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem. 1990 Aug 15;265(23):13472-83.
Results Reference
background
PubMed Identifier
9622410
Citation
Rosselli M, Keller PJ, Dubey RK. Role of nitric oxide in the biology, physiology and pathophysiology of reproduction. Hum Reprod Update. 1998 Jan-Feb;4(1):3-24. doi: 10.1093/humupd/4.1.3.
Results Reference
background
PubMed Identifier
15069080
Citation
Foster MW, Stamler JS. New insights into protein S-nitrosylation. Mitochondria as a model system. J Biol Chem. 2004 Jun 11;279(24):25891-7. doi: 10.1074/jbc.M313853200. Epub 2004 Apr 6.
Results Reference
background
PubMed Identifier
15688001
Citation
Hess DT, Matsumoto A, Kim SO, Marshall HE, Stamler JS. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol. 2005 Feb;6(2):150-66. doi: 10.1038/nrm1569.
Results Reference
background
PubMed Identifier
25385721
Citation
Morielli T, O'Flaherty C. Oxidative stress impairs function and increases redox protein modifications in human spermatozoa. Reproduction. 2015 Jan;149(1):113-23. doi: 10.1530/REP-14-0240. Epub 2014 Nov 10.
Results Reference
background
PubMed Identifier
11574660
Citation
Herrero MB, de Lamirande E, Gagnon C. Tyrosine nitration in human spermatozoa: a physiological function of peroxynitrite, the reaction product of nitric oxide and superoxide. Mol Hum Reprod. 2001 Oct;7(10):913-21. doi: 10.1093/molehr/7.10.913.
Results Reference
background
PubMed Identifier
16580379
Citation
Vignini A, Nanetti L, Buldreghini E, Moroni C, Ricciardo-Lamonica G, Mantero F, Boscaro M, Mazzanti L, Balercia G. The production of peroxynitrite by human spermatozoa may affect sperm motility through the formation of protein nitrotyrosine. Fertil Steril. 2006 Apr;85(4):947-53. doi: 10.1016/j.fertnstert.2005.09.027. Epub 2006 Mar 9.
Results Reference
background

Learn more about this trial

Relationship Between Nitric Oxide (NO) in Follicular Fluid and Sperm Fertilization Ability

We'll reach out to this number within 24 hrs